Vanguard disaggregates holdings; affiliates to report separately (IDYA)
Rhea-AI Filing Summary
Ideaya Biosciences Inc Schedule 13G/A amendment: The Vanguard Group reports 0 shares beneficially owned and 0% of the class. The filing explains that on January 12, 2026 Vanguard underwent an internal realignment and its subsidiaries will report ownership on a disaggregated basis.
The amendment states, in accordance with SEC Release No. 34-39538, that The Vanguard Group, Inc. no longer has beneficial ownership over securities held by those subsidiaries and/or business divisions. Signature is shown by Ashley Grim on March 27, 2026.
Positive
- None.
Negative
- None.
Insights
Vanguard disaggregation reduces reported parent ownership to zero; subsidiary reporting now appears separate.
The filing shows 0 shares and 0% beneficial ownership for The Vanguard Group after an internal realignment described as effective January 12, 2026. The text cites SEC Release No. 34-39538 and states subsidiaries will report separately.
Implications depend on subsidiary filings; subsequent amendments or separate 13G/A entries by Vanguard affiliates will show the actual holdings. Timing and amounts for those affiliate filings are not included here.
FAQ
What did The Vanguard Group report for IDEAYA (IDYA)?
Why does Vanguard show zero ownership in this 13G/A for IDYA?
Does this filing disclose how many Ideaya shares Vanguard affiliates hold?
When was the Schedule 13G/A signed and by whom?
Does the filing state any party has over 5% of IDYA due to Vanguard holdings?